Apeximmune Therapeutics Inc.

Biotechnology company · South San Francisco, California, United States

Apeximmune Therapeutics Inc. is a biotechnology company headquartered in South San Francisco, California, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $399,618 in total, most recently in 2023.

www.apeximmune.comProfile compiled from public records. Is this your company? Request a correction or update

Apeximmune Therapeutics at a glance

Typebiotechnology company

HeadquartersSouth San Francisco, California, United States

Employees (self-reported, 2023)10

What does Apeximmune Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $399,618 in total (2023). NIH funding came from the National Cancer Institute.

Frequently asked questions about Apeximmune Therapeutics

Where is Apeximmune Therapeutics headquartered?

Apeximmune Therapeutics Inc. is headquartered in South San Francisco, California, United States.

What does Apeximmune Therapeutics do?

Apeximmune Therapeutics Inc. is a biotechnology company.

Similar companies

Alector, Inc.South San Francisco, California, United States
Vaxart, Inc.South San Francisco, California, United States
Denali Therapeutics Inc.South San Francisco, California, United States
Aligos Therapeutics, Inc.South San Francisco, California, United States
PROFUSA, Inc.South San Francisco, California, United States
Quince Therapeutics, Inc.South San Francisco, California, United States
Allogene Therapeutics, Inc.South San Francisco, California, United States
Sutro Biopharma, Inc.South San Francisco, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences